#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypertriglyceridaemia Primitive neuroectodermal tumour Endocrine ophthalmopathy Myelodysplastic syndrome with excess blasts Hodgkin's disease Medullary thyroid cancer Leukoencephalopathy Epileptic encephalopathy Glomerulonephritis membranoproliferative Haemophilia A without inhibitors Vernal keratoconjunctivitis Arterial tortuosity syndrome Congenital ectodermal dysplasia Ichthyosis Angiosarcoma recurrent More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent Breast angiosarcoma Castleman’s disease Inclusion body myositis – Trials in Disease Testicular leiomyosarcoma – Life with Disease Glomerulonephritis membranous – Diagnostics Primary immunodeficiency syndrome – Basic Information Carcinoid syndrome – Basic Information Acquired haemophilia – Basic Information Familial haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Kbp-336 ZIGAKIBART Sitagliptin TETANUS TOXOID Tryptophan Brivaracetam Ivabradine Oxymetazoline Hydrochloride Xenon (129Xe) Octreotide Hydrochloride Adct-402 Gs-4182 Clindamycin Phosphate Phenazone Calcium Polystyrene Sulfonate His203-Crm197 Sxr1096 Cobamamide Masupirdine Benzocaine More therapies…

    Learn about Your Condition

    Endocarditis bacterial Follicular lymphoma Prodromal Alzheimer's disease Asthmatic crisis Palmoplantar pustulosis Frostbite Neuroendocrine carcinoma Sarcoma Febrile neutropenia Immune-mediated enterocolitis Hypothyroidism Mite allergy Androgenetic alopecia Pharyngeal cancer stage I Adenocarcinoma gastric More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Use of Methylprednisolone Sodium Succinate for Treating Patients with Acute Myocarditis and Mildly Reduced Heart Function

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocarditis post infection
    • Viral myocarditis
    • Myocarditis
    Investigated Drugs:
    • Methylprednisolone Sodium Succinate
    • Sodium Chloride
    Belgium Italy Slovenia Spain

  • Study on the Effects of Injectable Gentamicin for Patients with Moderate to Severe Congenital Ichthyosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ichthyosis
    Investigated Drugs:
    • Gentamicin Sulfate
    France

  • Study on Bevacizumab for Patients with Symptomatic Cerebral Arteriovenous Malformations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral arteriovenous malformation haemorrhagic
    Investigated Drugs:
    • Bevacizumab
    France

  • Study on Dapagliflozin for Slowing Kidney Disease in Adolescents and Young Adults with Alport Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    • Placebo
    Germany

  • Study on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Belgium Germany The Netherlands Spain

  • Study on Repotrectinib for Children and Young Adults with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Alterations

    Recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Repotrectinib
    Denmark France Italy Spain
Previous Page
1 … 433 434 435 436 437 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!